You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
If your chronic pain isn't responding to medication, or you can't tolerate the side effects, your doctor may prescribe one of our neurostimulators or drug pumps. These implantable devices may help you manage your pain, restore your ability to do everyday activities, decrease your need for oral pain medications, and improve your quality of life.1-4 For more than 30 years they have enhanced the lives of people with chronic pain.
Spinal cord stimulation (also called neurostimulation therapy) and targeted drug delivery are two proven, long-term pain therapies. Both use surgically placed devices.
A spinal cord stimulator (also known as a neurostimulator) sends mild electrical pulses to an area near your spine. These pulses disrupt the pain signals traveling between the spinal cord and the brain so you may feel relief.
Drug pumps deliver pain medication directly to the fluid around the spinal cord, instead of the blood stream, providing pain relief with a small fraction of the medication needed if taken orally.4,5
Ohnmeiss DD, Rashbaum RF, Bogdanffy GM. Prospective outcome evaluation of spinal cord stimulation in patients with intractable leg pain. Spine. 1996;21:1344-1350.
Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132:179-188.
Deer T, Chapple I, Classen A, et al. Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. Pain Med. 2004;5:6-13.
Hamza M, Doleys D, Wells M, et al. Prospective study of 3-year follow-up of lowdose intrathecal opioids in the management of chronic nonmalignant pain.Pain Med. 2012;13:1304-1313.
Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician. 2007;10:357-366.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.